Patent ID: 6329404
Filing Date: 2001-12-11
Classification: A61K,A61P,Y10S

Abstract:
A pharmaceutical composition comprising an insulin sensitivity enhancer in combination with an insulin secretion enhancer, wherein the insulin sensitivity enhancer is selected from the group consisting of:(1) 5-(4-(2-(3-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione or its pharmacologically acceptable salt,(2) 5-(4-(2-(4-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione or its pharmacologically acceptable salt,(3) 5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione or its pharmacologically acceptable salt, and(4) 5-(4-(2-(6-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione or its pharmacologically acceptable salt.